K183176 is an FDA 510(k) clearance for the Endotoxin Activity Assay (EAA). Classified as Assay, Endotoxin Activity, Chemiluminescent (product code NGS), Class II - Special Controls.
Submitted by Spectral Medical, Inc. (Toronto, CA). The FDA issued a Cleared decision on March 12, 2019 after a review of 116 days - within the typical 510(k) review window.
This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3210 - the FDA microbiology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.